These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 32915671)

  • 1. Continuous Light Does Not Affect Atherosclerosis in APOE*3-Leiden.CETP Mice.
    Schilperoort M; van den Berg R; Coomans CP; Khedoe PPSJ; Ramkisoensing A; Boekestijn S; Wang Y; Berbée JFP; Meijer JH; Biermasz NR; Rensen PCN; Kooijman S
    J Biol Rhythms; 2020 Dec; 35(6):598-611. PubMed ID: 32915671
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Atherothrombosis model by silencing of protein C in APOE*3-Leiden.CETP transgenic mice.
    Jongejan YK; Eikenboom JCJ; Gijbels MJJ; Berbée JFP; van Vlijmen BJM
    J Thromb Thrombolysis; 2021 Oct; 52(3):715-719. PubMed ID: 34052976
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Human CETP aggravates atherosclerosis by increasing VLDL-cholesterol rather than by decreasing HDL-cholesterol in APOE*3-Leiden mice.
    de Vries-van der Weij J; Zadelaar S; Toet K; Havekes LM; Kooistra T; Rensen PC
    Atherosclerosis; 2009 Sep; 206(1):153-8. PubMed ID: 19345354
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Disruption of circadian rhythm by alternating light-dark cycles aggravates atherosclerosis development in APOE*3-Leiden.CETP mice.
    Schilperoort M; van den Berg R; Bosmans LA; van Os BW; Dollé MET; Smits NAM; Guichelaar T; van Baarle D; Koemans L; Berbée JFP; Deboer T; Meijer JH; de Vries MR; Vreeken D; van Gils JM; Willems van Dijk K; van Kerkhof LWM; Lutgens E; Biermasz NR; Rensen PCN; Kooijman S
    J Pineal Res; 2020 Jan; 68(1):e12614. PubMed ID: 31599473
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cholesteryl ester transfer protein decreases high-density lipoprotein and severely aggravates atherosclerosis in APOE*3-Leiden mice.
    Westerterp M; van der Hoogt CC; de Haan W; Offerman EH; Dallinga-Thie GM; Jukema JW; Havekes LM; Rensen PC
    Arterioscler Thromb Vasc Biol; 2006 Nov; 26(11):2552-9. PubMed ID: 16946130
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cannabinoid type 1 receptor inverse agonism attenuates dyslipidemia and atherosclerosis in APOE∗3-Leiden.CETP mice.
    van Eenige R; Ying Z; Tambyrajah L; Pronk ACM; Blomberg N; Giera M; Wang Y; Coskun T; van der Stelt M; Rensen PCN; Kooijman S
    J Lipid Res; 2021; 62():100070. PubMed ID: 33766515
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Serum amyloid A augments the atherogenic effects of cholesteryl ester transfer protein.
    Ji A; Trumbauer AC; Noffsinger VP; de Beer FC; Webb NR; Tannock LR; Shridas P
    J Lipid Res; 2023 May; 64(5):100365. PubMed ID: 37004910
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Both transient and continuous corticosterone excess inhibit atherosclerotic plaque formation in APOE*3-leiden.CETP mice.
    Auvinen HE; Wang Y; Princen H; Romijn JA; Havekes LM; Smit JW; Meijer OC; Biermasz NR; Rensen PC; Pereira AM
    PLoS One; 2013; 8(5):e63882. PubMed ID: 23717502
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Expression of type IIA secretory phospholipase A2 inhibits cholesteryl ester transfer protein activity in transgenic mice.
    Hurt-Camejo E; Gautier T; Rosengren B; Dikkers A; Behrendt M; Grass DS; Rader DJ; Tietge UJ
    Arterioscler Thromb Vasc Biol; 2013 Dec; 33(12):2707-14. PubMed ID: 24115030
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Time-restricted feeding attenuates hypercholesterolaemia and atherosclerosis development during circadian disturbance in APOE∗3-Leiden.CETP mice.
    In Het Panhuis W; Schönke M; Modder M; Tom HE; Lalai RA; Pronk ACM; Streefland TCM; van Kerkhof LWM; Dollé MET; Depuydt MAC; Bot I; Vos WG; Bosmans LA; van Os BW; Lutgens E; Rensen PCN; Kooijman S
    EBioMedicine; 2023 Jul; 93():104680. PubMed ID: 37356205
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Increased atherosclerosis in ApoE and LDL receptor gene knock-out mice as a result of human cholesteryl ester transfer protein transgene expression.
    Plump AS; Masucci-Magoulas L; Bruce C; Bisgaier CL; Breslow JL; Tall AR
    Arterioscler Thromb Vasc Biol; 1999 Apr; 19(4):1105-10. PubMed ID: 10195942
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Deficiency of Cholesteryl Ester Transfer Protein Protects Against Atherosclerosis in Rabbits.
    Zhang J; Niimi M; Yang D; Liang J; Xu J; Kimura T; Mathew AV; Guo Y; Fan Y; Zhu T; Song J; Ackermann R; Koike Y; Schwendeman A; Lai L; Pennathur S; Garcia-Barrio M; Fan J; Chen YE
    Arterioscler Thromb Vasc Biol; 2017 Jun; 37(6):1068-1075. PubMed ID: 28428219
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Deuterium-reinforced polyunsaturated fatty acids protect against atherosclerosis by lowering lipid peroxidation and hypercholesterolemia.
    Berbée JFP; Mol IM; Milne GL; Pollock E; Hoeke G; Lütjohann D; Monaco C; Rensen PCN; van der Ploeg LHT; Shchepinov MS
    Atherosclerosis; 2017 Sep; 264():100-107. PubMed ID: 28655430
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Resveratrol protects against atherosclerosis, but does not add to the antiatherogenic effect of atorvastatin, in APOE*3-Leiden.CETP mice.
    Berbée JF; Wong MC; Wang Y; van der Hoorn JW; Khedoe PP; van Klinken JB; Mol IM; Hiemstra PS; Tsikas D; Romijn JA; Havekes LM; Princen HM; Rensen PC
    J Nutr Biochem; 2013 Aug; 24(8):1423-30. PubMed ID: 23337345
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Altered Clock and Lipid Metabolism-Related Genes in Atherosclerotic Mice Kept with Abnormal Lighting Condition.
    Zhu Z; Hua B; Shang Z; Yuan G; Xu L; Li E; Li X; Sun N; Yan Z; Qian R; Lu C
    Biomed Res Int; 2016; 2016():5438589. PubMed ID: 27631008
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Niacin increases HDL by reducing hepatic expression and plasma levels of cholesteryl ester transfer protein in APOE*3Leiden.CETP mice.
    van der Hoorn JW; de Haan W; Berbée JF; Havekes LM; Jukema JW; Rensen PC; Princen HM
    Arterioscler Thromb Vasc Biol; 2008 Nov; 28(11):2016-22. PubMed ID: 18669886
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ritonavir protects against the development of atherosclerosis in APOE*3-Leiden mice.
    den Boer MA; Westerterp M; de Vries-van der Weij J; Wang Y; Hu L; Espirito Santo SM; Kooistra T; Reiss P; Romijn JA; Havekes LM; Rensen PC
    Atherosclerosis; 2010 Jun; 210(2):381-7. PubMed ID: 20060117
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Atorvastatin increases HDL cholesterol by reducing CETP expression in cholesterol-fed APOE*3-Leiden.CETP mice.
    de Haan W; van der Hoogt CC; Westerterp M; Hoekstra M; Dallinga-Thie GM; Princen HM; Romijn JA; Jukema JW; Havekes LM; Rensen PC
    Atherosclerosis; 2008 Mar; 197(1):57-63. PubMed ID: 17868678
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Overexpression of Cholesteryl Ester Transfer Protein Increases Macrophage-Derived Foam Cell Accumulation in Atherosclerotic Lesions of Transgenic Rabbits.
    Gao S; Wang X; Cheng D; Li J; Li L; Ran L; Zhao S; Fan J; Liu E
    Mediators Inflamm; 2017; 2017():3824276. PubMed ID: 29317793
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Genetic Architecture of Atherosclerosis in Mice: A Systems Genetics Analysis of Common Inbred Strains.
    Bennett BJ; Davis RC; Civelek M; Orozco L; Wu J; Qi H; Pan C; Packard RR; Eskin E; Yan M; Kirchgessner T; Wang Z; Li X; Gregory JC; Hazen SL; Gargalovic PS; Lusis AJ
    PLoS Genet; 2015 Dec; 11(12):e1005711. PubMed ID: 26694027
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.